These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
257 related articles for article (PubMed ID: 7689464)
1. AMPA, but not NMDA, receptor antagonism is neuroprotective in gerbil global ischaemia, even when delayed 24 h. Sheardown MJ; Suzdak PD; Nordholm L Eur J Pharmacol; 1993 Jun; 236(3):347-53. PubMed ID: 7689464 [TBL] [Abstract][Full Text] [Related]
2. Postischemic blockade of AMPA but not NMDA receptors mitigates neuronal damage in the rat brain following transient severe cerebral ischemia. Nellgård B; Wieloch T J Cereb Blood Flow Metab; 1992 Jan; 12(1):2-11. PubMed ID: 1345757 [TBL] [Abstract][Full Text] [Related]
3. Protection against post-ischemic behavioral pathology by the alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid (AMPA) antagonist 2,3-dihydroxy-6-nitro-7-sulfamoyl-benzo(f)quinoxaline (NBQX) in the gerbil. Judge ME; Sheardown MJ; Jacobsen P; Honoré T Neurosci Lett; 1991 Dec; 133(2):291-4. PubMed ID: 1667818 [TBL] [Abstract][Full Text] [Related]
4. Comparative patch clamp studies on the kinetics and selectivity of glutamate receptor antagonism by 2,3-dihydroxy-6-nitro-7-sulfamoyl-benzo(F)quinoxaline (NBQX) and 1-(4-amino-phenyl)-4-methyl-7,8-methyl-endioxyl-5H-2,3-benzodiaze pine (GYKI 52466). Parsons CG; Gruner R; Rozental J Neuropharmacology; 1994 May; 33(5):589-604. PubMed ID: 7523977 [TBL] [Abstract][Full Text] [Related]
5. Neuronal damage induced by beta-N-oxalylamino-L-alanine, in the rat hippocampus, can be prevented by a non-NMDA antagonist, 2,3-dihydroxy-6-nitro-7-sulfamoyl-benzo(F)quinoxaline. Willis CL; Meldrum BS; Nunn PB; Anderton BH; Leigh PN Brain Res; 1993 Nov; 627(1):55-62. PubMed ID: 7507397 [TBL] [Abstract][Full Text] [Related]
6. NMDA receptor antagonism, but not AMPA receptor antagonism attenuates induced ischaemic tolerance in the gerbil hippocampus. Bond A; Lodge D; Hicks CA; Ward MA; O'Neill MJ Eur J Pharmacol; 1999 Sep; 380(2-3):91-9. PubMed ID: 10513567 [TBL] [Abstract][Full Text] [Related]
7. Over-additive protective effect of dizocilpine and NBQX against neuronal damage. Lippert K; Welsch M; Krieglstein J Eur J Pharmacol; 1994 Mar; 253(3):207-13. PubMed ID: 7911083 [TBL] [Abstract][Full Text] [Related]
8. Evaluation of glycine site antagonists of the NMDA receptor in global cerebral ischaemia. Hicks CA; Ward MA; Ragumoorthy N; Ambler SJ; Dell CP; Dobson D; O'Neill MJ Brain Res; 1999 Feb; 819(1-2):65-74. PubMed ID: 10082862 [TBL] [Abstract][Full Text] [Related]
9. Quinoxaline derivatives: structure-activity relationships and physiological implications of inhibition of N-methyl-D-aspartate and non-N-methyl-D-aspartate receptor-mediated currents and synaptic potentials. Randle JC; Guet T; Bobichon C; Moreau C; Curutchet P; Lambolez B; de Carvalho LP; Cordi A; Lepagnol JM Mol Pharmacol; 1992 Feb; 41(2):337-45. PubMed ID: 1371583 [TBL] [Abstract][Full Text] [Related]
10. Are NMDA or AMPA/kainate receptor antagonists more efficacious in the delayed treatment of excitotoxic neuronal injury? Prehn JH; Lippert K; Krieglstein J Eur J Pharmacol; 1995 Jan; 292(2):179-89. PubMed ID: 7720791 [TBL] [Abstract][Full Text] [Related]
11. The pharmacology of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate (AMPA)/kainate antagonists and their role in cerebral ischaemia. Gill R Cerebrovasc Brain Metab Rev; 1994; 6(3):225-56. PubMed ID: 7529037 [TBL] [Abstract][Full Text] [Related]
12. Pharmacological characterization of non-NMDA subtypes of glutamate receptor in the neonatal rat hemisected spinal cord in vitro. Zeman S; Lodge D Br J Pharmacol; 1992 Jun; 106(2):367-72. PubMed ID: 1382781 [TBL] [Abstract][Full Text] [Related]
13. Neuroprotective effects of the AMPA antagonist PNQX in oxygen-glucose deprivation in mouse hippocampal slice cultures and global cerebral ischemia in gerbils. Montero M; Nielsen M; Rønn LC; Møller A; Noraberg J; Zimmer J Brain Res; 2007 Oct; 1177():124-35. PubMed ID: 17894933 [TBL] [Abstract][Full Text] [Related]
14. Functional changes of N-methyl-D-aspartic acid and alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionate channels in gerbil hippocampal CA1, in relation to postischemic enhancement of glutamate receptor-mediated responses. Ikemune K; Mitani A; Namba S; Kataoka K; Arai T Neurosci Lett; 1999 Nov; 275(2):125-8. PubMed ID: 10568515 [TBL] [Abstract][Full Text] [Related]
15. Protection against ischemic hippocampal CA1 damage in the rat with a new non-NMDA antagonist, NBQX. Diemer NH; Jørgensen MB; Johansen FF; Sheardown M; Honoré T Acta Neurol Scand; 1992 Jul; 86(1):45-9. PubMed ID: 1325729 [TBL] [Abstract][Full Text] [Related]
16. The neuroprotective and hypothermic effect of GYKI-52466, a non-competitive alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid-antagonist on histological and behavioural variables in the gerbil global ischemia model. Gyertyán I; Gigler G; Simó A Brain Res Bull; 1999 Oct; 50(3):179-86. PubMed ID: 10566979 [TBL] [Abstract][Full Text] [Related]
17. NMDA and AMPA/kainate glutamate receptors modulate dentate neurogenesis and CA3 synapsin-I in normal and ischemic hippocampus. Bernabeu R; Sharp FR J Cereb Blood Flow Metab; 2000 Dec; 20(12):1669-80. PubMed ID: 11129783 [TBL] [Abstract][Full Text] [Related]
18. NMDA-receptor blockers but not NBQX, an AMPA-receptor antagonist, inhibit spreading depression in the rat brain. Nellgård B; Wieloch T Acta Physiol Scand; 1992 Dec; 146(4):497-503. PubMed ID: 1283483 [TBL] [Abstract][Full Text] [Related]
19. 2,3-Dihydroxy-6-nitro-7-sulfamoyl-benzo(F)quinoxaline: a neuroprotectant for cerebral ischemia. Sheardown MJ; Nielsen EO; Hansen AJ; Jacobsen P; Honoré T Science; 1990 Feb; 247(4942):571-4. PubMed ID: 2154034 [TBL] [Abstract][Full Text] [Related]
20. NMDA and non-NMDA receptor gene expression following global brain ischemia in rats: effect of NMDA and non-NMDA receptor antagonists. Pellegrini-Giampietro DE; Pulsinelli WA; Zukin RS J Neurochem; 1994 Mar; 62(3):1067-73. PubMed ID: 8113793 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]